1. Home
  2. MDXH vs AUID Comparison

MDXH vs AUID Comparison

Compare MDXH & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • AUID
  • Stock Information
  • Founded
  • MDXH 2003
  • AUID 2009
  • Country
  • MDXH Belgium
  • AUID United States
  • Employees
  • MDXH N/A
  • AUID N/A
  • Industry
  • MDXH
  • AUID Computer Software: Prepackaged Software
  • Sector
  • MDXH
  • AUID Technology
  • Exchange
  • MDXH Nasdaq
  • AUID Nasdaq
  • Market Cap
  • MDXH 93.1M
  • AUID 88.5M
  • IPO Year
  • MDXH 2021
  • AUID N/A
  • Fundamental
  • Price
  • MDXH $1.96
  • AUID $5.87
  • Analyst Decision
  • MDXH Strong Buy
  • AUID
  • Analyst Count
  • MDXH 2
  • AUID 0
  • Target Price
  • MDXH $7.00
  • AUID N/A
  • AVG Volume (30 Days)
  • MDXH 145.0K
  • AUID 28.2K
  • Earning Date
  • MDXH 02-26-2025
  • AUID 11-07-2024
  • Dividend Yield
  • MDXH N/A
  • AUID N/A
  • EPS Growth
  • MDXH N/A
  • AUID N/A
  • EPS
  • MDXH N/A
  • AUID N/A
  • Revenue
  • MDXH $84,708,000.00
  • AUID $758,638.00
  • Revenue This Year
  • MDXH $27.57
  • AUID N/A
  • Revenue Next Year
  • MDXH $20.09
  • AUID N/A
  • P/E Ratio
  • MDXH N/A
  • AUID N/A
  • Revenue Growth
  • MDXH 33.01
  • AUID 97.40
  • 52 Week Low
  • MDXH $1.55
  • AUID $4.62
  • 52 Week High
  • MDXH $4.44
  • AUID $13.63
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 38.10
  • AUID 48.17
  • Support Level
  • MDXH $1.97
  • AUID $5.26
  • Resistance Level
  • MDXH $2.25
  • AUID $5.98
  • Average True Range (ATR)
  • MDXH 0.16
  • AUID 0.39
  • MACD
  • MDXH -0.04
  • AUID 0.00
  • Stochastic Oscillator
  • MDXH 0.00
  • AUID 53.71

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

Share on Social Networks: